The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

Year in Review: Lung Cancer

Balazs Halmos

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

Cancer Screening Molecular Tools

Fengting Yan

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang